UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mycobacterium tuberculosis ClpP1 and ClpP2 function together in protein degradation and are required for viability in vitro and during infection

PLoS pathogens, 2012-02, Vol.8 (2), p.e1002511-e1002511

2012

Volltextzugriff (PDF)

Midlife adiposity predicts cognitive decline in the prospective Multicenter AIDS Cohort Study

Neurology, 2019-09, Vol.93 (10), p.465-465

2019

Volltextzugriff (PDF)

As Their Numbers Grow, COVID-19 "Long Haulers" Stump Experts

JAMA : the journal of the American Medical Association, 2020-10, Vol.324 (14), p.1381

Rubin, Rita

2020

Volltextzugriff (PDF)

When to adjust alpha during multiple testing: a consideration of disjunction, conjunction, and individual testing

Synthese (Dordrecht), 2021-12, Vol.199 (3-4), p.10969-11000

Rubin, Mark

2021

Volltextzugriff (PDF)

COVID-19 Vaccines vs Variants-Determining How Much Immunity Is Enough

JAMA : the journal of the American Medical Association, 2021-04, Vol.325 (13), p.1241

Rubin, Rita

2021

Volltextzugriff (PDF)

Striving for Diversity in Research Studies

The New England journal of medicine, 2021-10, Vol.385 (15), p.1429-1430

Rubin, Eric

2021

Volltextzugriff (PDF)

Donor-Specific Antibodies in Kidney Transplant Recipients

Clinical journal of the American Society of Nephrology, 2018-01, Vol.13 (1), p.182-192

Zhang, Rubin

2018

Volltextzugriff (PDF)

COVID-19's Crushing Effects on Medical Practices, Some of Which Might Not Survive

JAMA : the journal of the American Medical Association, 2020-07, Vol.324 (4), p.321

Rubin, Rita

2020

Volltextzugriff (PDF)

It Takes an Average of 17 Years for Evidence to Change Practice-the Burgeoning Field of Implementation Science Seeks to Speed Things Up

JAMA : the journal of the American Medical Association, 2023-04, Vol.329 (16), p.1333

Rubin, Rita

2023

Volltextzugriff (PDF)

As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2 "Variant of Interest"

JAMA : the journal of the American Medical Association, 2024-02, Vol.331 (5), p.382

Rubin, Rita

2024

Volltextzugriff (PDF)

From Positive to Negative to Positive Again—The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid

JAMA : the journal of the American Medical Association, 2022-06, Vol.327 (24), p.2380

Rubin, Rita

2022

Volltextzugriff (PDF)

The Challenges of Expanding Rapid Tests to Curb COVID-19

JAMA : the journal of the American Medical Association, 2020-11, Vol.324 (18), p.1813

Rubin, Rita

2020

Volltextzugriff (PDF)

When Does HARKing Hurt? Identifying When Different Types of Undisclosed Post Hoc Hypothesizing Harm Scientific Progress

Review of general psychology, 2017-12, Vol.21 (4), p.308-320

2017

Volltextzugriff (PDF)

The psychological effects of quarantining a city

BMJ (Online), 2020-01, p.m313

2020

Volltextzugriff (PDF)

Pregnant People's Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications

JAMA : the journal of the American Medical Association, 2021-03, Vol.325 (11), p.1027

Rubin, Rita

2021

Volltextzugriff (PDF)

Do p Values Lose Their Meaning in Exploratory Analyses? It Depends How You Define the Familywise Error Rate

Review of general psychology, 2017-09, Vol.21 (3), p.269-275

2017

Volltextzugriff (PDF)

Influenza’s Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store

JAMA : the journal of the American Medical Association, 2021-09, Vol.326 (10), p.899

Rubin, Rita

2021

Volltextzugriff (PDF)

Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease

PloS one, 2017-08, Vol.12 (8), p.e0182900-e0182900

2017

Volltextzugriff (PDF)

When Physicians Spread Unscientific Information About COVID-19

JAMA : the journal of the American Medical Association, 2022-03, Vol.327 (10), p.904

Rubin, Rita

2022

Volltextzugriff (PDF)

Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment

JAMA : the journal of the American Medical Association, 2022-06, Vol.327 (23), p.2281

Rubin, Rita

2022

Volltextzugriff (PDF)

Mechanical regulation of signaling pathways in bone

Gene, 2012-07, Vol.503 (2), p.179-193

2012

Volltextzugriff (PDF)

The Challenge of Preventing COVID-19 Spread in Correctional Facilities

JAMA : the journal of the American Medical Association, 2020-05, Vol.323 (18), p.1760

Rubin, Rita

2020

Volltextzugriff (PDF)

Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications

Clinical Microbiology Reviews, 2010-07, Vol.23 (3), p.590-615

2010

Volltextzugriff (PDF)

An overview of the 6th World Symposium on Pulmonary Hypertension

The European respiratory journal, 2019-01, Vol.53 (1), p.1802148

2019

Volltextzugriff (PDF)

Limits on Opioid Prescribing Leave Patients With Chronic Pain Vulnerable

JAMA : the journal of the American Medical Association, 2019-06, Vol.321 (21), p.2059

Rubin, Rita

2019

Volltextzugriff (PDF)

1 – 25 von 60.049

Menü

Weitere Dienste

Einstellungen

Mycobacterium tuberculosis ClpP1 and ClpP2 function together in protein degradation and are required for viability in vitro and during infection

Midlife adiposity predicts cognitive decline in the prospective Multicenter AIDS Cohort Study

As Their Numbers Grow, COVID-19 "Long Haulers" Stump Experts

When to adjust alpha during multiple testing: a consideration of disjunction, conjunction, and individual testing

COVID-19 Vaccines vs Variants-Determining How Much Immunity Is Enough

Striving for Diversity in Research Studies

Donor-Specific Antibodies in Kidney Transplant Recipients

COVID-19's Crushing Effects on Medical Practices, Some of Which Might Not Survive

It Takes an Average of 17 Years for Evidence to Change Practice-the Burgeoning Field of Implementation Science Seeks to Speed Things Up

As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2 "Variant of Interest"

From Positive to Negative to Positive Again—The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid

The Challenges of Expanding Rapid Tests to Curb COVID-19

When Does HARKing Hurt? Identifying When Different Types of Undisclosed Post Hoc Hypothesizing Harm Scientific Progress

The psychological effects of quarantining a city

Pregnant People's Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications

Do p Values Lose Their Meaning in Exploratory Analyses? It Depends How You Define the Familywise Error Rate

Influenza’s Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store

Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease

When Physicians Spread Unscientific Information About COVID-19

Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment

Mechanical regulation of signaling pathways in bone

The Challenge of Preventing COVID-19 Spread in Correctional Facilities

Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications

An overview of the 6th World Symposium on Pulmonary Hypertension

Limits on Opioid Prescribing Leave Patients With Chronic Pain Vulnerable

Aktive Filter

Suchergebnisse filtern